Anne Janin
Overview
Explore the profile of Anne Janin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
222
Citations
3664
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angeli E, Paris J, Le Tilly O, Desvignes C, Gapihan G, Boquet D, et al.
Exp Hematol Oncol
. 2024 Apr;
13(1):41.
PMID: 38622749
Despite major therapeutic advances for two decades, including the most recently approved anti-HER2 drugs, brain metastatic localizations remain the major cause of death for women with metastatic HER2 breast cancer....
2.
Hamdan D, Nguyen V, Paris J, Leboeuf C, El Bouchtaoui M, Espie M, et al.
Genes Dis
. 2024 Jan;
11(3):101003.
PMID: 38274368
No abstract available.
3.
Hamdan D, Gardair C, Pamoukdjian F, Peraldi Gardin M, Nakouri I, Leboeuf C, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38256221
Cutaneous squamous cell carcinomas in kidney-transplant recipients are frequent, with an increasing incidence linked to long immunosuppression durations and exposure to ultraviolet radiation. p53 is at the cornerstone of ultraviolet-induced...
4.
Matte A, Wilson A, Gevi F, Federti E, Recchiuti A, Ferri G, et al.
JCI Insight
. 2023 Sep;
8(20.
PMID: 37676741
Hereditary spherocytosis (HS) is the most common, nonimmune, hereditary, chronic hemolytic anemia after hemoglobinopathies. The genetic defects in membrane function causing HS lead to perturbation of the RBC metabolome, with...
5.
Bui T, Angeli E, El Bouchtaoui M, Gapihan G, Dao V, Paris J, et al.
Exp Hematol Oncol
. 2023 May;
12(1):46.
PMID: 37189165
Background: Clear-cell renal cell carcinomas (ccRCCs) are malignant tumors with high metastatic potential and resistance to treatments occurs almost constantly. Compared to primary tumors, there are still limited genomic data...
6.
Federti E, Matte A, Recchiuti A, Garello F, Ghigo A, El Nemer W, et al.
Hemasphere
. 2023 Mar;
7(3):e848.
PMID: 36874380
Drug repurposing is a valuable strategy for rare diseases. Sickle cell disease (SCD) is a rare hereditary hemolytic anemia accompanied by acute and chronic painful episodes, most often in the...
7.
Zerrouk S, Casoni P, Cervi E, Amirat R, Bousquet G, Leboeuf C, et al.
Phlebology
. 2023 Feb;
38(4):270-280.
PMID: 36852698
Objectives: Few studies compared both ultrasound and histological approaches for the same series of patients with chronic venous disease (CVD). We aimed to assess the diagnostic performances of duplex ultrasound...
8.
Matte A, Kosinski P, Federti E, Dang L, Recchiuti A, Russo R, et al.
Haematologica
. 2023 Feb;
108(9):2535-2541.
PMID: 36794508
No abstract available.
9.
Gorombei P, Guidez F, Ganesan S, Chiquet M, Pellagatti A, Goursaud L, et al.
Int J Mol Sci
. 2021 Oct;
22(19).
PMID: 34638998
During transformation, myelodysplastic syndromes (MDS) are characterized by reducing apoptosis of bone marrow (BM) precursors. Mouse models of high risk (HR)-MDS and acute myelogenous leukemia (AML) post-MDS using mutant NRAS...
10.
Matte A, Federti E, Kung C, Kosinski P, Narayanaswamy R, Russo R, et al.
J Clin Invest
. 2021 Apr;
131(10).
PMID: 33822774
Anemia in β-thalassemia is related to ineffective erythropoiesis and reduced red cell survival. Excess free heme and accumulation of unpaired α-globin chains impose substantial oxidative stress on β-thalassemic erythroblasts and...